The recent decision by the United States to remove Venezuela from its list of countries failing to meet international counternarcotics commitments could lead to significant changes in the country’s approach to drug-related issues. This move signals a shift in U.S. policy towards Venezuela, acknowledging progress under interim President Delcy Rodríguez in tackling drug-trafficking organizations.
Previously, Venezuela was classified among nations not adhering to international efforts against drug trafficking. However, the Trump administration’s recognition of Venezuela’s improvements marks a departure from past assessments and could influence future U.S.-Venezuelan relations. This decision also reflects the broader U.S. strategy of engaging with Latin American countries on drug control issues.
In contrast, Colombia remains on the U.S. list of countries that have failed demonstrably to meet counternarcotics obligations. Despite its ongoing efforts, the White House noted that Colombia must further enhance its actions against coca cultivation, cocaine production, and drug-trafficking networks to be removed from this list in the future.
President Trump has expressed that Colombia could potentially be removed from the list if it shows greater progress in the coming year. Colombian officials have committed to targeting the entire drug-trafficking chain, including illicit crops, production facilities, and trafficking routes as part of their strategy to meet international standards.
This U.S. decision underscores Washington’s ongoing focus on collaborative efforts across Latin America to combat the illegal drug trade. While Venezuela is no longer classified as failing in its counternarcotics obligations, both Venezuela and Colombia continue to be recognized as major drug-transit or illicit drug-producing countries for fiscal year 2027.